Axim Biotechnologies Stock Price Prediction
| AXIM Stock | USD 0 0 33.33% |
Oversold Vs Overbought
35
Oversold | Overbought |
Using Axim Biotechnologies hype-based prediction, you can estimate the value of Axim Biotechnologies from the perspective of Axim Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Axim Biotechnologies to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Axim because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Axim Biotechnologies after-hype prediction price | USD 0.002386 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Axim |
Axim Biotechnologies After-Hype Price Prediction Density Analysis
As far as predicting the price of Axim Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Axim Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Axim Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Axim Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Axim Biotechnologies' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Axim Biotechnologies' historical news coverage. Axim Biotechnologies' after-hype downside and upside margins for the prediction period are 0.00 and 20.25, respectively. We have considered Axim Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Axim Biotechnologies is out of control at this time. Analysis and calculation of next after-hype price of Axim Biotechnologies is based on 3 months time horizon.
Axim Biotechnologies Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Axim Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axim Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Axim Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 20.25 | 0.00 | 0.01 | 5 Events / Month | 1 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 19.28 |
|
Axim Biotechnologies Hype Timeline
Axim Biotechnologies is presently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Axim is forecasted to increase in value after the next headline, with the price projected to jump to 0.002386 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is estimated to be 19.28%, whereas the daily expected return is presently at -0.18%. The volatility of related hype on Axim Biotechnologies is about 67470.01%, with the expected price after the next announcement by competition of -0.01. Axim Biotechnologies currently holds 5.06 M in liabilities with Debt to Equity (D/E) ratio of 1.36, which is about average as compared to similar companies. Axim Biotechnologies has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Axim Biotechnologies until it has trouble settling it off, either with new capital or with free cash flow. So, Axim Biotechnologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Axim Biotechnologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Axim to invest in growth at high rates of return. When we think about Axim Biotechnologies' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out Axim Biotechnologies Basic Forecasting Models to cross-verify your projections.Axim Biotechnologies Related Hype Analysis
Having access to credible news sources related to Axim Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Axim Biotechnologies' future price movements. Getting to know how Axim Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Axim Biotechnologies may potentially react to the hype associated with one of its peers.
Axim Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Axim price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Axim using various technical indicators. When you analyze Axim charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Axim Biotechnologies Predictive Indicators
The successful prediction of Axim Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Axim Biotechnologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Axim Biotechnologies based on analysis of Axim Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Axim Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Axim Biotechnologies's related companies.
Story Coverage note for Axim Biotechnologies
The number of cover stories for Axim Biotechnologies depends on current market conditions and Axim Biotechnologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Axim Biotechnologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Axim Biotechnologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Axim Biotechnologies Short Properties
Axim Biotechnologies' future price predictability will typically decrease when Axim Biotechnologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Axim Biotechnologies often depends not only on the future outlook of the potential Axim Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Axim Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 138.1 M |
Other Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.